Literature DB >> 17541553

Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients.

Katri Saukkonen1, Päivi Lakkisto, Marjut Varpula, Tero Varpula, Liisa-Maria Voipio-Pulkki, Ville Pettilä, Kari Pulkki.   

Abstract

OBJECTIVE: To investigate the concentration of cell-free plasma DNA and its association with organ dysfunction and hospital mortality in intensive care unit patients. DESIGN AND
SETTING: Prospective cohort study in a medical and two medical-surgical intensive care units in a university hospital. PATIENTS: 228 critically ill patients admitted to the ICUs between January 2004 and July 2005. MEASUREMENTS AND
RESULTS: Blood samples were collected as soon as possible after ICU admission, the following morning, and 48[Symbol: see text]h after the second sample. The cell-free plasma DNA was measured by real-time quantitative PCR assay for the beta-globin gene. Physiological and mortality data were collected to the clinical database. Hospital mortality rate and SOFA scores were primary outcome measures. The maximum plasma DNA concentrations were correlated significantly with APACHE II points and with maximum SOFA scores. Cell-free plasma DNA concentrations were higher in hospital non-survivors than in survivors (median 9,366 vs. 6,506 GE/ml). Using logistic regression analysis, the maximum plasma DNA was an independent predictor of hospital mortality.
CONCLUSIONS: The maximum plasma DNA concentration measured during the first 96[Symbol: see text]h of intensive care is associated with the degree of organ dysfunction and disease severity. Moreover, the maximum DNA concentration is independently associated with hospital mortality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541553     DOI: 10.1007/s00134-007-0686-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  16 in total

1.  Plasma DNA as a prognostic marker in trauma patients.

Authors:  Y M Lo; T H Rainer; L Y Chan; N M Hjelm; R A Cocks
Journal:  Clin Chem       Date:  2000-03       Impact factor: 8.327

2.  Effects of blood-processing protocols on cell-free DNA quantification in plasma.

Authors:  Dorine W Swinkels; Erwin Wiegerinck; Eric A P Steegers; Jacques B de Kok
Journal:  Clin Chem       Date:  2003-03       Impact factor: 8.327

3.  Rapid screening for HLA-B27 by a TaqMan-PCR assay using sequence-specific primers and a minor groove binder probe, a novel type of TaqMan trade mark probe.

Authors:  Sylvain Kuzio; Kuzio Sylvain; Aurélie Hanguehard; Hanguehard Aurélie; Marc Morelle; Morelle Marc; Christophe Ronsin; Ronsin Christophe
Journal:  J Immunol Methods       Date:  2004-04       Impact factor: 2.303

4.  Elevated cell-free serum DNA detected in patients with myocardial infarction.

Authors:  Christine P-Y Chang; Rhu-Hsin Chia; Tsu-Lan Wu; Kuo-Chien Tsao; Chien-Feng Sun; James T Wu
Journal:  Clin Chim Acta       Date:  2003-01       Impact factor: 3.786

5.  Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

Authors:  Y M Lo; M S Tein; T K Lau; C J Haines; T N Leung; P M Poon; J S Wainscoat; P J Johnson; A M Chang; N M Hjelm
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

6.  Plasma DNA as cell death marker in elderly patients.

Authors:  G J Fournié; F Martres; J P Pourrat; C Alary; M Rumeau
Journal:  Gerontology       Date:  1993       Impact factor: 5.140

7.  The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum.

Authors:  Ning Jiang; David S Pisetsky
Journal:  J Leukoc Biol       Date:  2004-12-15       Impact factor: 4.962

8.  Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; A de Mendonça; F Cantraine; R Moreno; J Takala; P M Suter; C L Sprung; F Colardyn; S Blecher
Journal:  Crit Care Med       Date:  1998-11       Impact factor: 7.598

9.  Cell-free plasma DNA as a prognostic marker in intensive treatment unit patients.

Authors:  S Wijeratne; A Butt; S Burns; K Sherwood; O Boyd; R Swaminathan
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

10.  Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients.

Authors:  Andrew Rhodes; Stephen J Wort; Helen Thomas; Paul Collinson; E David Bennett
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more
  28 in total

Review 1.  Emerging infection and sepsis biomarkers: will they change current therapies?

Authors:  Lauren Jacobs; Hector R Wong
Journal:  Expert Rev Anti Infect Ther       Date:  2016-08-17       Impact factor: 5.091

Review 2.  The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness.

Authors:  Kevin C Ma; Edward J Schenck; Maria A Pabon; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2018-02-01       Impact factor: 21.405

3.  Systemic inflammation and liver injury following hemorrhagic shock and peripheral tissue trauma involve functional TLR9 signaling on bone marrow-derived cells and parenchymal cells.

Authors:  Roop Gill; Xiangcai Ruan; Christoph L Menzel; Seung Namkoong; Patricia Loughran; David J Hackam; Timothy R Billiar
Journal:  Shock       Date:  2011-02       Impact factor: 3.454

4.  Effects of extracellular DNA on plasminogen activation and fibrinolysis.

Authors:  Andrey A Komissarov; Galina Florova; Steven Idell
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

5.  Cell-free DNA as a potential marker to predict carbon tetrachloride-induced acute liver injury in rats.

Authors:  Benjamin Fredrick Gruenbaum; Matthew Boyko; Bertha Delgado; Amos Douvdevany; Shaun Evan Gruenbaum; Israel Melamed; Micky Gideon; Evaldas Cesnulis; Yoram Shapira; Alexander Zlotnik
Journal:  Hepatol Int       Date:  2012-11-22       Impact factor: 6.047

6.  Peritoneal Cell-free DNA: an innovative method for determining acute cell damage in peritoneal membrane and for monitoring the recovery process after peritonitis.

Authors:  Grazia Maria Virzì; Sabrina Milan Manani; Alessandra Brocca; Vincenzo Cantaluppi; Massimo de Cal; Silvia Pastori; Ilaria Tantillo; Roberto Zambon; Carlo Crepaldi; Claudio Ronco
Journal:  J Nephrol       Date:  2015-05-27       Impact factor: 3.902

7.  Quantification of circulating cell-free DNA in the serum of patients with obstructive sleep apnea-hypopnea syndrome.

Authors:  Liang Ye; Guan-Hua Ma; Ling Chen; Min Li; Jia-Lin Liu; Kun Yang; Qing-Yun Li; Ning Li; Huan-Ying Wan
Journal:  Lung       Date:  2010-07-29       Impact factor: 2.584

8.  Prognostic value of cell-free plasma DNA in patients with cardiac arrest outside the hospital: an observational cohort study.

Authors:  Francisco Arnalich; Marta Menéndez; Verónica Lagos; Enrique Ciria; Angustias Quesada; Rosa Codoceo; Juan José Vazquez; Eduardo López-Collazo; Carmen Montiel
Journal:  Crit Care       Date:  2010-03-29       Impact factor: 9.097

9.  Fatal outcome in bacteremia is characterized by high plasma cell free DNA concentration and apoptotic DNA fragmentation: a prospective cohort study.

Authors:  Reetta Huttunen; Taru Kuparinen; Juulia Jylhävä; Janne Aittoniemi; Risto Vuento; Heini Huhtala; Janne Laine; Jaana Syrjänen; Mikko Hurme
Journal:  PLoS One       Date:  2011-07-01       Impact factor: 3.240

10.  Plasma levels of mitochondrial and nuclear DNA in patients with massive pulmonary embolism in the emergency department: a prospective cohort study.

Authors:  Francisco Arnalich; Maria Constanza Maldifassi; Enrique Ciria; Rosa Codoceo; Jaime Renart; Carmen Fernández-Capitán; Rafael Herruzo; Francisco Garcia-Rio; Eduardo López-Collazo; Carmen Montiel
Journal:  Crit Care       Date:  2013-05-24       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.